Ngenxa yezehlo zokubuyiselwa kwevalve ye-mitral kunye ne-mitral valve stenosis kwinqanaba lehlabathi, ngo-2026, isifo sentliziyo se-mitral valve kwimakethi yokutshintshwa kwevalvu yentliziyo ye-transcatheter siya kufikelela kukukhula okukhulu kwama-23.1%.
PR Newswire-PR Newswire Selbyville, Delaware, USA, January 18, 2021-Ngokwengxelo yamva nje “Intengiso yeTranscatheter Heart Valve Replacement Market ngeMveliso (iTranscatheter Aortic Valve Replacement, Transcatheter Mitral) Ukulungiswa kweValve kunye nokutshintshwa, indawo ye-transcatheter pulmonary valve replacement), iindlela (indlela transfemoral, indlela transapical), isicelo (isifo sentliziyo valve mitral, mitral valve sentliziyo, pulmonary valve heart disease), ukusetyenziswa ekupheleni (izibhedlele, cath lab), imbonakalo yengingqi, iindlela amaxabiso, ukhuphiswano kwimarike isabelo kunye noqikelelo 2026 "ngo: Global market Insights, Inc, 2026, ixabiso lemarike yotyando lokutshintshwa kwevalvu yentliziyo ye-transcatheter iya kuba ngaphezulu kwe-19.5 yeebhiliyoni. Idola.
Iinkqubo zembuyekezo ezithandekayo kuMntla Melika naseYurophu ziya kukhuthaza ukukhula kwemarike. Isigqibo se-Medicare National Coverage Decision ngumgaqo-nkqubo opapashwe yi-Medicare kunye namaZiko eeNkonzo ze-Medicaid (CMS) ukuvumela ezi zivalo zentliziyo ukuba zigutyungelwe bubungqina obuxhasayo e-United States. Ngo-2019, i-CMS yahlaziya umgaqo-nkqubo we-Medicare wembuyekezo ye-transcatheter aortic valves. Inkqubo yoTshintsho (TAVR). Xa utyando lwenziwa ngokuhambelana nemiyalelo evunyiweyo ye-FDA, umgaqo-nkqubo omtsha wesizwe uya kuqhubeka ugubungela i-TAVR ngoPhuhliso loBungqina (CED). Ukongeza, iBelgium kunye neFransi zibonelela ngembuyekezo kwiimpawu ezithile, ngelixa kwamanye amazwe, ukubuyiselwa kwezixhobo ezinjalo kunqunywe. Kuphela eFransi, eJamani naseSwitzerland yimbuyekezo yeentlobo ezahlukeneyo zotyando ezahlukeneyo. EJamani naseSwitzerland, iindleko zotyando ngendlela ye-apical ziphezulu. Lo mgaqo-nkqubo wembuyekezo unyusa inani labantu abafumana inkqubo ye-TAVR.
Cela isampulu yale ngxelo yophando@ https://www.gminsights.com/request-sample/detail/3170
Umdla okhulayo wabavelisi kumazwe asakhasayo afana noMbindi Mpuma kunye ne-Afrika uya kuqhuba ukwandiswa kwemarike yokutshintshwa kwevalvu yentliziyo ye-transcatheter. Inani elikhulu labantu abahlukeneyo kuMbindi Mpuma kunye neAfrika bachaphazeleka kakhulu sisifo senhliziyo. Ke ngoko, abavelisi bamanye amazwe bajolise ekuhlangabezaneni nemfuno kunye nokubonelela ngee-valve zentliziyo ye-transcatheter. Ukuxhaphaka kwe-aortic valve stenosis kuMbindi Mpuma kwandise ukwamkelwa kotyando lokutshintshwa kwevalve yentliziyo ye-transcatheter. Ke ngoko, kuMbindi Mpuma naseAfrika, abavelisi bevalve ye-aortic babona amathuba amakhulu okukhula.
Icandelo lemarike ye-transcatheter pulmonary valve replacement liqikelelwe ngaphezulu kwe-537 yezigidi zeedola ngo-2019. Ngokomzekelo, izigulane ezine-arterial trunks kunye nezigulane ezine-pulmonary atresia okanye utyando lwe-Ross kufuneka luthathe indawo ye-transcatheter pulmonary valve. Ukongeza, i-valve ye-transcatheter pulmonary inciphisa inani lotyando lwentliziyo ekufuneka isigulane silwenze ebomini baso. Lo mba ukwanegalelo kwimfuno yeevalvu ze-pulmonary transcatheter.
Indlela ye-transapical kwimarike yokutshintshwa kwevalve yentliziyo ye-transcatheter idlule i-US $ 1.16 yezigidigidi ngo-2019. Indlela ye-transapical yindlela ekhethwayo kuba ukusondela komsebenzisi kwivalve kunokuwela ngokulula ivalve yendalo kunye nenkqubo yokuhambisa. Le ndlela inokuthintela inkqubo yokuhambisa ukuba idlule kwi-aortic arch, ngaloo ndlela inciphisa umngcipheko we-stroke kwi-transcatheter aortic valve replacement. Ukongeza, indlela ye-transapical yindlela yokuzikhethela uninzi lwababoneleli bezempilo kuba ibonelela ngelona zinga lisezantsi leengxaki ezinxulumene nendlela. Ezi zinto zinokuqhuba imfuno ye-transcatheter heart valves.
Ngenxa yezehlo zehlabathi lokuphindaphinda kwe-mitral kunye ne-mitral valve stenosis, imarike yokutshintshwa kwevalvu yentliziyo ye-transcatheter yezicelo zesifo sentliziyo ye-mitral valve iya kubonisa izinga lokukhula elingaphezulu kwe-23.1% ngo-2026. Ngokwamanqaku apapashiweyo, abantu abangaphezu kwezigidi ezi-4 IUnited States ithwaxwa yi-mitral regurgitation, kwaye izehlo zonyaka zimalunga nama-50,000. Kucetyiswa ukuba izigulane ezikule meko zingene endaweni ye-transcatheter mitral valve replacement. Ke ngoko, imfuno ye-transcatheter heart valves ikhula ngokukhawuleza. Izixhobo zokutshintsha ivalve ye-Transcatheter mitral ziphantsi kovavanyo olunokwenzeka, oluya kukhuthaza ngakumbi inani lezigulane ezithatha indawo ye-transcatheter mitral valve.
Kuqikelelwa ukuba ngo-2026, icandelo lesibhedlele kwi-transcatheter heart valve replacement market liya kukhula kwi-CAGR ye-14.1%. Izibhedlele ziya kufumana imbuyekezo efanelekileyo, enyanzelisa izigulane phakathi kwamanye amaziko ezonyango ukuba zikhethe izibhedlele ze-transcatheter heart valve replacement surgery ngenxa yeendleko eziphezulu zale mi sebenzi. Ukongeza, ukunyuka kwenyathelo likarhulumente kulawulo lwezifo zesivalo ngomnye umba wokwandiswa kwecandelo lezibhedlele.
IBrazil ilawula imarike yokutshintshwa kwevalvu yentliziyo ye-transcatheter eLatin America. Iqhutywa ngabantu abakhulileyo abakhulayo abaphethwe sisifo se-aortic valve, iBrazil yathatha i-US $ 47 yezigidi ngo-2019. Kwiminyaka embalwa edlulileyo, inani lezigulana ezine-non-rheumatic calcified aortic disease eBrazil liye landa kakhulu. Ke ngoko, kwiminyaka yakutshanje, ukwamkelwa kwasekhaya kwetekhnoloji yokutshintsha i-valve ye-transcatheter yentliziyo kuye kwanda, okuye kwakhokelela ekwandeni kwemfuno kunye nokubonelela ngee-valve zentliziyo ye-transcatheter. Ukwanda ngokukhawuleza kwenani lezibhedlele kweli lizwe kunye nobukho obuqinileyo babadlali abaziwayo bezoshishino abatyala imali ekuphuhliseni i-valve ye-transcatheter heart valves baye bakhuthaza ngakumbi imfuno yemarike.
Ezinye zeenkampani ezinkulu ezisebenza kwimarike yokutshintsha ivalvu yentliziyo ye-transcatheter ziquka i-4C Medical Technologies, i-Abbott, iBoston Scientific, i-Edward Lifesciences, i-HighLife Medical, i-JC Medical, i-LivaNova, i-Medtronic plc kunye ne-Neovasc. Abathathi-nxaxheba kwishishini bahlala bejolise ekukhululweni kweemveliso ezintsha zokwandisa indawo yabo yejografi kunye nesiseko sabathengi.
IGlobal Market Insights, Inc., enekomkhulu eDelaware, luphando lwemarike yehlabathi kunye nomnikezeli wenkonzo yokubonisana, ebonelela ngeengxelo zophando ezidityanisiweyo kunye nezilungelelanisiweyo kunye neenkonzo zokucebisa ukukhula. Iingxelo zethu zobukrelekrele beshishini kunye neengxelo zophando kushishino zibonelela abathengi ngengqiqo ecacileyo kunye nedatha yentengiso ebonakalayo, eyilwe ngokukodwa kwaye iboniswe ukunceda izigqibo zobuchule. Ezi ngxelo zineenkcukacha zenzelwe ngeendlela zophando olusemthethweni kwaye zingasetyenziselwa kumashishini abalulekileyo afana nekhemistri, izinto eziphambili, iteknoloji, amandla avuselelekayo kunye ne-biotechnology.
UArun Hegde (Arun Hegde) INkampani yaseMelika yoThengiso lweNkampani yeGlobal Market Insights yeNkampani ifowuni: 1-302-846-7766 yaMahala: 1-888-689-0688 imeyile: [I-imeyile ekhuselweyo]
I-transcatheter-heart-valve.png Ngo-2026, izinga lokukhula kwemarike yokutshintshwa kwevalvu yentliziyo ye-transcatheter kulindeleke ukuba ibe yi-17.6%: GMI: Abona badlali bemakethi abakhulu ekutshintsheni ivalvu yentliziyo ye-transcatheter baquka i-4C Medical Technologies, Abbott, Boston Scientific, Edwards Life. Inzululwazi, i-HighLife Medical, i-JC Medical, i-LivaNova, i-Medtronic plc.
Ixesha lokuposa: Jan-19-2021
